61. The Evaluation And Management Of Hyperlipidemia In HIV Infection The Evaluation and Management of hyperlipidemia In HIV Infection Reported forNATAP by Carl J. Fichtenbaum, MD, Associate Professor of Clinical Medicine http://www.natap.org/2000/icaac/ICAAC_hyperlipidemia_11070.htm

The Evaluation and Management of Hyperlipidemia In HIV Infection Reported for NATAP by Carl J. Fichtenbaum, M.D., Associate Professor of Clinical Medicine, University of Cincinnati College of Medicine, Division of Infectious Diseases, University of Cincinnati College of Medicine ICAAC Report from Mike Norton, PA, Greenwich House, New York City. ICAAC, Tuesday, September 19, 2000. Symposium titled: Lipodystrophy and metabolic complications of HIV There were 4 separate presentations during this 2.5 hour session. William Lewis from Emory University was the first speaker. He made a compelling case for nucleoside induced mitochondrial dysfunction/destruction. Steven Grinspoon of Harvard presented glucose dysregulation. He noted that the changes being seen in treated patients are hyperinsulinemia and that this is often a prelude to diabetes. Typically one observes at the beginning of glucose dyregulation a normal fasting glucose but an abnormal 2 hour glucose after a 75gram glucose challenge. He called this state compensated normoglycemia.

62. Project ImPACT Hyperlipidemia Project ImPACT hyperlipidemia. The APhA Foundation has completedProject ImPACT hyperlipidemia, a national demonstration project http://www.connectforhealth.org/ProjectImPACTHyperlipidemia.htm

Project ImPACT: Hyperlipidemia The APhA Foundation has completed Project ImPACT: Hyperlipidemia, a national demonstration project made possible by a grant from The abstract for the peer reviewed research article in the Journal of the American Pharmaceutical Association entitled Pharmaceutical Care and Results in Project ImPACT: Hyperlipidemia is provided below: Objective: To demonstrate that pharmacists, working collaboratively with patients and physicians and having immediate access to objective point-of-care patient data, promote patient persistence and compliance with prescribed dyslipidemic therapy that enables patients to achieve their National Cholesterol Education Program (NCEP) goals. Design: Observational study. Participants: 26 community-based ambulatory care pharmacies: independent, chain–professional, chain–grocery store, home health/home infusion, clinic, health maintenance organization/managed care. Main Outcome Measures: Rates of patient persistence and compliance with medication therapy and achievement of target therapeutic goals. Results: In a population of 397 patients over an average period of 24.6 months, observed rates for persistence and compliance with medication therapy were 93.6% and 90.1%, respectively, and 62.5% of patients had reached and were maintained at their NCEP lipid goal at the end of the project.

63. HealingWell.com - Medifocus Guides - Hyperlipidemia HealingWell Medcenter Medifocus Guide hyperlipidemia/Hypercholesterolemia(CR008) Introduction What are the most common symptoms of hyperlipidemia? http://www.healingwell.com/medcenter/hyperlipidemia.asp

Search Site: Search Web: HealingWell Medcenter Medifocus Guide Hyperlipidemia/Hypercholesterolemia Introduction Cholesterol (also called lipid) is a fat-like substance that deposits in the walls of blood vessels. It can contribute to the development of heart disease in certain individuals. Hypercholesterolemia is the clinical term for high levels of cholesterol in the blood. Other related terms used are high cholesterol, hyperlipidemia, and dyslipidemia. While cholesterol is the most commonly referred-to element of the lipid profile, there are several elements that are tested, with differing significance of elevated or low levels. The desirable levels of the different elements vary somewhat depending on the presence of other risk factors of coronary artery disease (CAD). Hyperlipidemia is known to be a key factor in the development of atherosclerosis (plaques that cause blockage of blood vessels) and is the greatest risk factor for the development of CAD. In the U.S., 500,000 men and women die of CAD each year. High cholesterol is not always due to dietary intake of saturated foods. There are also hereditary disorders of cholesterol over-production and deposition. This is called familial hypercholesterolemia and can be difficult to treat.

64. Hyperlipidemia An Approach to hyperlipidemia. Thomas hyperlipidemia. It is not necessaryto stop estrogen replacement in patients with hyperlipidemia. Fish Oil. http://www.bouldermedicalcenter.com/Articles/hyperlipidemia.htm

An Approach to Hyperlipidemia Thomas Higgins, MD, MSPH Nanci Grayson, MS, RD SCREENING GUIDELINES: We have summarized below the current national recommendations. These recommendations need to be modified for individual patients. The rationale for screening for cholesterol problems rests on the observations that there is a direct relationship between cholesterol level and the risk of heart attacks and that lowering levels (at least in high-risk patients) leads to a reduction in heart attacks. More recently, other problems related to arteriosclerosis such as stroke have also shown to be correlated with cholesterol levels. As a result, screening should be done at least once every five years for all persons age 20 and over. On May 15, 2001 the National Cholesterol Education Program Total Cholesterol: stratified according the following criteria: HDL Cholesterol: "Good Cholesterol"; it is a negative risk factor for heart attack and is stratified according the following criteria: Very High — above 75 mg/dL (associated with the "longevity syndrome")

65. Cigarette Smoking, Dietary Hyperlipidemia, And Experimental Athe McGilI, Jr. DATE; 1988 TITLE CIGARETTE SMOKING, DIETARY hyperlipidemia,AND EXPERIMENTAL ATHEROSCLEROSIS IN THE BABOON. CITATION http://tobaccodocuments.org/pm/2063594156.html

T obacco D ocuments ... Help Philip Morris: 2063594156 Overview Basic Search Cigarette Smoking, Dietary Hyperlipidemia, and Experimental Atherosclerosis in the Baboon. Date: 1988 Length: 1 page Jump To Images! http://tobaccodocuments.org/pm/2063594156.html [Create Footnote] Author: ... View Related Documents Date Loaded: 07 Jun 1999 CUSTOMIZE DOCUMENT VIEW: Printer-Friendly View View Range: Page 1 of 1 Highlight Terms: Hide Citation Image Rotation: None Left Right Flip Image Size: Formatted OCR thumb small medium full-size large very large OCR Text Alignment: Hide OCR Left of Image Above Image Left Formatted Above Formatted OCR Only Page 1: Log in for PDF and more options! CUSTOMIZE DOCUMENT VIEW: Printer-Friendly View View Range: Page 1 of 1 Highlight Terms: Hide Citation Image Rotation: None Left Right Flip Image Size: Formatted OCR thumb small medium full-size large very large OCR Text Alignment: Hide OCR Left of Image Above Image Left Formatted Above Formatted OCR Only

66. Physician Education In Hyperlipidemia Management Physician Education in hyperlipidemia Management The Impact on Collaboration.BARBARA S. CZERWINSKI, PhD, DAVID J. HYMAN, MD, MPH http://www.sma.org/smj/97july5.htm

Physician Education in Hyperlipidemia Management: The Impact on Collaboration BARBARA S. CZERWINSKI, PhD, DAVID J. HYMAN, MD, MPH, ELAINE V. JONES, MSN, LYNNE W. SCOTT, MA, and PETER H. JONES, MD, Houston, Tex THE IMPORTANCE of cholesterol management through diet modification and antihyperlipidemia drugs was emphasized in 1988 by guidelines from the National Cholesterol Education Program (NCEP) Expert Panel.1 In 1991, 46 million office visits were made for treatment of hyperlipidemia in the United States,2 costing an estimated $3.7 billion. The average office visit charge was $30, and the average cost for laboratory testing per visit was $50. The NCEP recommends diet and behavioral counseling as major components of hypercholesterolemia treatment. Counseling, however, is time consuming, and most physicians have limited time to counsel and to monitor their patients for behavioral changes necessary to positively alter cholesterol abnormalities. Collaborative practice, defined as physicians and other health care professionals working together as teams to promote patient health, has received renewed interest in this era of health care reform and limited resources.3-5 Collaborative practice has produced improved outcomes among (1) subjects in cardiovascular clinical trials,6 (2) patients in critical care settings,7 and (3) low-birth-weight infants.8 There has been little research on how to encourage physicians to adopt collaborative practice or on whether collaborative practice can be achieved via continuing medical education (CME) programs.

67. Hyperlipidemia Hypercholesterolemia hyperlipidemia/ Hypercholesterolemia. Introduction. Other related termsused are high cholesterol, hyperlipidemia, and dyslipidemia. http://www.medicalinfoplus.com/conditions/hyperlipidemia.html

Alphabetical Listing Of Conditions and Diseases Abdominal Aortic Aneurysm Acute Myelogenous Leukemia Adult Asthma Adult Constipation ... Home Hyperlipidemia/ Hypercholesterolemia Introduction Cholesterol (also called lipid) is a fat-like substance that deposits in the walls of blood vessels. It can contribute to the development of heart disease in certain individuals. Hypercholesterolemia is the clinical term for high levels of cholesterol in the blood. Other related terms used are high cholesterol, hyperlipidemia, and dyslipidemia. While cholesterol is the most commonly referred-to element of the lipid profile, there are several elements that are tested, with differing significance of elevated or low levels. The desirable levels of the different elements vary somewhat depending on the presence of other risk factors of coronary artery disease (CAD). Hyperlipidemia is known to be a key factor in the development of atherosclerosis (plaques that cause blockage of blood vessels) and is the greatest risk factor for the development of CAD. In the U.S., 500,000 men and women die of CAD each year. High cholesterol is not always due to dietary intake of saturated foods. There are also hereditary disorders of cholesterol over-production and deposition. This is called familial hypercholesterolemia and can be difficult to treat.

68. Hospital Practice: Detecting And Correcting Hyperlipidemia Detecting and Correcting hyperlipidemia RALPH R. HALL lipid levels. Diabetesand hyperlipidemia are a potentially deadly combination. The http://www.hosppract.com/issues/1998/11/dmmhall.htm

Detecting and Correcting Hyperlipidemia RALPH R. HALL University of Missouri Case Commentary: STEPHEN A. BRUNTON University of California, Irvine The dangers of elevated serum cholesterol levelsand in particular, of increased concentrations of small, dense lipoproteinshave been fully delineated. Although effective therapies are available, too many physicians fail to look for hypercholesterolemia, or fail to treat it effectively. Adhering to therapeutic guidelines and encouraging patient compliance can be lifesaving. Dr. Hall is Professor of Medicine Emeritus, University of Missouri-Kansas City School of Medicine, and Medical Education Director, Colorado Physician Education Program. Dr. Brunton is Clinical Professor, Department of Family Medicine, University of California, Irvine, College of Medicine, and Executive Vice President, Education and Scientific Affairs, Clinical Communications Group, Greenwich, Ct. Case 1 Presentation A 56-year-old postmenopausal woman, whose employer had recently changed insurance plans, presented to her new primary care physician. Two years earlier she had been diagnosed with non-insulin-dependent diabetes mellitus (NIDDM) and had been treated with a maximum dose of a sulfonylurea. Her most recent glycosylated hemoglobin level was 8.6%. The patient did not have a history of heart disease, but treatment with simvastatin, 20 mg a day, had been initiated by her former physician because of hyperlipidemia. The pretreatment lipid levels had been total cholesterol, 242 mg/dL; high-density lipoprotein (HDL), 43 mg/dL; low-density lipoprotein (LDL), 199 mg/dL; and triglycerides, 430 mg/dL. After eight weeks of treatment, the total cholesterol level had fallen to 179 mg/dL, the LDL to 134 mg/dL, and the triglycerides to 280 mg/dL. The HDL level was 45 mg/dL.

69. Diabetes Self-Management - Hyperlipidemia hyperlipidemia Published in the May/June 2000 issue. A blanket term for abnormallyhigh levels of lipids, such as cholesterol, in the bloodstream. http://www.diabetesselfmanagement.com/article.cfm?aid=396&sid=6

70. Florida State University College Of Medicine Digital Library hyperlipidemia Clinical Resources. Miscellaneous hyperlipidemia Clinical ResourcesHealth Reviews for Primary Care Providers on the Internet Homepage http://fsumed-dl.slis.ua.edu/clinical/cardiology/cardiovascular/hyperlipidemia.h

Clinical Resources by Topic: Cardiovascular Disorders Hyperlipidemia Clinical Resources Pediatrics Geriatrics Genetics Clinical Guidelines ... Miscellaneous Resources See also: Cardiovascular Clinical Procedure Resources Atherosclerosis Clinical Resources General Cardiovascular Disorders Clinical Resources Hyperlipidemia Prevention and Screening Resources ... Patient/Family Resources Harrison's Principles of Internal Medicine 15th Ed.-2001: Table of contents Medical Library subscription INFO Chapter 344: Disorders of Lipoprotein Metabolism Table of contents Introduction: Access document The Hyperlipoproteinemias Access document Approach to the Patient Access document Treatment Access document Hypocholesterolemia Access document Larsen: Williams Textbook of Endocrinology 10th Ed.-2003 (MD Consult): Table of contents Medical Library subscription INFO Chapter 34 - Disorders of Lipid Metabolism: Access document Lipid Biochemistry and Cholesterol Metabolism: Access document Introduction: Access document Classes of Lipids: Structure and Function: Access document Cholesterol Biosynthesis and the Low-Density Lipoprotein Receptor Pathway: Access document Metabolism of Dietary Lipids: Access document Triglyceride and Free Fatty Acid Metabolism: Access document Plasma Lipoproteins: Apolipoproteins, Receptors, and Enzymes:

71. Florida State University College Of Medicine Digital Library Cardiovascular Diseases. hyperlipidemia Prevention and Screening Resources. hyperlipidemia(Keyword search) List of documents. Miscellaneous hyperlipidemia http://fsumed-dl.slis.ua.edu/prevmedicine/disease-prevention/cardiovasculardisor

Preventive Medicine Resources by Topic: Cardiovascular Diseases Hyperlipidemia Prevention and Screening Resources Clinical Guidelines Miscellaneous Resources See also: Atherosclerosis Prevention and Screening Resources General Preventive Medicine Resources Hyperlipidemia Patient/Family Resources ... Hyperlipidemia Clinical Resources Noble: Textbook of Primary Care Medicine, 3rd Ed.-2001 (MD Consult): Table of contents Medical Library subscription INFO Chapter 71 - Lipid Disorders: Diagnosis, Management, and Controversy: Access document The Efficacy of Primary Prevention: Access document The Efficacy of Secondary Prevention: Access document The Role of Dietary Intervention: Access document Age Groups to Screen: Access document Screening for Dyslipidemia: Access document Braunwald-Heart Disease: A Textbook of Cardiovascular Medicine 6th Ed.-2001 (MD Consult): Table of contents Medical Library subscription INFO Chapter 33 - Lipid-Lowering Trials: Access document Guide to Clinical Preventive Services, 3rd Ed., Table of contents Screening for Lipid Disorders - What’s New from the USPSTF: Access document Screening for Lipid Disorders - Recommendations and Rationale: Access document Screening for Lipid Disorders - Summary of the Evidence: Access document Clinical Guidelines American Heart Association: Homepage Scientific Statements: List of documents Monounsaturated Fatty Acids and Risk of Cardiovascular Disease (1999): Access document Antioxidant Consumption and Risk of Coronary Heart Disease: Emphasis on Vitamin C, Vitamin E, and beta-Carotene (1999):

72. The Drug Monitor - Hyperlipidemia / Dyslipidemia - Nasr Anaizi, PhD Management of hyperlipidemia During the past 10 years dramatic progress has madein the field of lipidlowering drugs and the management of hyperlipidemia. http://www.thedrugmonitor.com/hyperlipidemia.html

Please read the Antiinfectives General Rx Renal Rx Transplant Rx ... Clinical Tools Objectives Review the main risk factors for coronary heart disease (CHD) (per NCEP) Review of the basics of lipoprotein metabolism and the major lipid disorders. Review the guidelines for non-pharmacologic and pharmacologic management of hyperlipidemia. Review the current pharmacologic options for the treatment of hyperlipidemia. Review the pharmacology of atorvastatin. Mechanism of action Pharmacokinetics Efficacy Side effects Drug interactions Discuss the latest clinical trials comparing atorvastatin to other statins. Coronary heart disease (CHD) is one the leading causes of disability and death in the US. Although the etiology of CHD is multifactorial, there is an impress amount of evidence from experimental, epidemiological, and clinical studies indicating a strong association between coronary artery atherosclerosis and hypercholesterolemia below summarizes the main risk factors predisposing patients for the development of CHD: Table 1 Risk Factors For Coronary Heart Disease (CHD) Age Genetic factor: Family history of "premature" CHD

73. 33. Prospective Study Of Hyperlipidemia In ART-Naïve Subjects Taking Combivir/A Prospective Study of hyperlipidemia in ARTNaïve Subjects Taking Combivir/Abacavir(COM/ABC), COM/Nelfinavir (NFV), or Stavudine (d4T)/Lamivudine (3TC)/NFV http://www.retroconference.org/2002/Abstract/13081.htm

Abstract E-mail Abstract Author Add To Itinerary Session Search Abstracts ... Program Session 7 Oral Abstract Session Opportunistic Infections and Complications of Antiretroviral Therapy Session Time: Monday, 10 am - 12:30 pm Room 6E Prospective Study of Hyperlipidemia in ART-Naïve Subjects Taking Combivir/Abacavir (COM/ABC), COM/Nelfinavir (NFV), or Stavudine (d4T)/Lamivudine (3TC)/NFV (ESS40002) P. Kumar* , A. Rodriguez-French , M. Thompson , K. Tashima , V. Williams , P. Wannamaker , and M. Shaefer Georgetown Univ. Med. Ctr., Washington, DC; San Fernando Hosp., Panama City, Panama; AIDS Res. Consortium, Atlanta, GA; The Miriam Hosp., Providence, RI; and GlaxoSmithKline, Res. Triangle Park, NC Background: Hyperlipidemia is a common side effect of HAART therapy. The effect that non-PI-containing regimens have on the development of hyperlipidemia and fat redistribution (FR) is not fully known. Our objectives were to evaluate changes in fasting metabolic parameters, clinical evaluations of FR, safety, and efficacy in subjects treated with COM/ABC vs COM/NFV vs d4T/3TC/NFV for 96 weeks.

74. Diseases And Conditions -- Discovery Health -- Familial Combined Hyperlipidemia Familial combined hyperlipidemia is an inherited disease that causes highlevels of cholesterol and/or triglycerides in the blood. http://health.discovery.com/diseasesandcond/encyclopedia/26.html

familial combined hyperlipidemia By Evan M. Sisson, Pharm.D., MHA, CDE Familial combined hyperlipidemia is an inherited disease that causes high levels of cholesterol and/or triglycerides in the blood. What is going on in the body? This condition may cause high cholesterol , high triglycerides , or both. These are each two types of fat in the body. Normally, the liver makes a low amount of cholesterol. When a person has this disease, the liver produces too much cholesterol. Other problems occur with fat metabolism, too. These problems depend on which specific abnormal gene was inherited. This condition increases a person's risk of having clogged arteries from atherosclerosis , which may lead to a heart attack stroke , or other complications. What are the signs and symptoms of the condition? This condition often causes no symptoms. Once the arteries become clogged, a heart attack stroke , or other problems may occur. What are the causes and risks of the condition? This condition is inherited and occurs in about 1% of people in the US. What can be done to prevent the condition?

75. Hyperlipidemia hyperlipidemia INDICATIONS FOR WHO SHOULD BE TREATED? hyperlipidemia refers to elevatedblood levels of lipids (fats), including cholesterol and triglycerides. http://www.uptodate.com/patient_info/topicpages/topics/Hrt_dis/7390.asp

Hyperlipidemia INTRODUCTION WHAT ARE THE TYPES OF LIPIDS AND HOW ARE THEY MEASURED? Total cholesterol LDL cholesterol ... WHERE TO GET MORE INFORMATION Robert S Rosenson, MD UpToDate performs a continuous review of over 290 journals and other resources. Updates are added as important new information is published. The literature review for UpToDate version 11.1 is current through December 2002; this topic was last changed on January 14, 2003. These materials are for your general information and are not a substitute for medical advice. You should contact your physician or other healthcare provider with any questions about your health, treatment, or care. Do not contact UpToDate or the physician authors of these materials. INTRODUCTION The good news is that lipid levels can almost always be lowered with a combination of diet, weight loss, exercise, and medications. As lipid levels fall, so does the risk of developing CHD, as well as the risk of suffering a stroke. And, it is not too late if CHD is already present: lipid-lowering treatment in people with CHD can be lifesaving. WHAT ARE THE TYPES OF LIPIDS AND HOW ARE THEY MEASURED?

76. Hyperlipidemia - AnsMe.com Dictionary (define) Dictionary hyperlipidemia. Show Definition. Sounds Similar. Relations. Rhymes.Translate. Definition for hyperlipidemia. hyperlipidemia (noun) -. http://define.ansme.com/words/h/hyperlipidemia.html

Search: Web Sites Dictionary - Define Dictionary - Sounds Like Dictionary - Relations Dictionary - Rhymes Dictionary - Translate Sponsors Index Hyperion hyperkalemia hyperkinetic syndrome hyperlink ... hyperlipidaemia hyperlipidemia hyperlipoidaemia hyperlipoidemia hyperlipoproteinemia hypermarket ... hypermedia Dictionary - hyperlipidemia Show Definition Sounds Similar Relations Rhymes Translate Definition for hyperlipidemia hyperlipidemia (noun) presence of excess lipids in the blood Synonyms: lipemia lipaemia lipidemia lipidaemia ... hyperlipoidaemia Source: WordNet ® 1.7, © 2001 Princeton University All other brands are property of their respective owners. Directory Dictionary AIM Smileys Contact Us

77. Hyperlipidemia And Pancreatitis During..., Annals 15 Feb 96 hyperlipidemia and Pancreatitis during Pregnancy in Two Sisters with a Mutationin the Lipoprotein Lipase Gene. Annals of Internal Medicine 15 Feb 96. http://www.acponline.org/journals/annals/15feb96/2sisters.htm

Annals of Internal Medicine Current Issue Past Issues Library for Internists Subscriptions ... Email this page Annals of Internal Medicine Hyperlipidemia and Pancreatitis during Pregnancy in Two Sisters with a Mutation in the Lipoprotein Lipase Gene Annals of Internal Medicine 15 February 1996. 124:425-428. Leonard M. Keilson, MD, MPH; Calvin P.H. Vary, PhD; Dennis L. Sprecher, MD; and Roger Renfrew, MD Objective: To explore genetic mechanisms for pregnancy-associated pancreatitis and hyperlipidemia in two sisters. Design: Case history. Setting: Tertiary care facility with outpatient follow-up. Patients: Two sisters with acute pancreatitis and the acute respiratory distress syndrome were admitted (patient 1) or transferred (patient 2) to an intensive care setting with severely elevated triglyceride levels. Patient 1 was in the last trimester of pregnancy; patient 2 was 1 month post-partum. Both patients were of French Canadian ancestry. Intervention: Acute treatment was directed at stabilizing both patients medically (with fat restriction) and one patient surgically (patient 2). Treatment with fat restriction, weight loss, and gemfibrozil was continued after hospitalization. Results: Through DNA sequencing, we detected a mutation at amino acid residue 188 of lipoprotein lipase (LPL), reflecting product from one allele of the LPL gene in which a glutamine residue was substituted for a glycine (gly188

78. ACP-ASIM - 2003 Annual Session Email this page. Managing a Patient with hyperlipidemia. This session covered thetreatment of hyperlipidemia within the context of recently published trials. http://www.acponline.org/vas2001/sessions/hyper.htm

Annual Session 2003 Main Page Education Information Course Finder Day Planner Pre-Session Courses Be Sure Not to Miss ... ACP-ASIM Learning Center General Information Don't Miss Convocation Exhibit Hall Information 5K Fun Run and Walk ... Housing and Travel Instructions Guest Activities/San Diego Information Guest Activities Program/Spotlight on San Diego Printer-friendly format Email this page ACP-ASIM Annual Session 2003 Registration Information To register, call Customer Service at 800-523-1546, ext. 2600 or 215-351-2600. Education Information Course Finder: up-to-date course listings Day Planner CME Information Overview of Annual Session Pre-Session Courses Sessions Requiring Reservations Introduction Hands-on Computer Tutorials Meet and Eat with the Professor Workshops ACP-ASIM Learning Center Computers in Practice Handouts Program Support Faculty Index Disclosure of Significant Relationships PDA Information Annual Session Navigator : Users of Palm and Pocket PC handheld computers can now download an electronic guide to the Annual Session. General Information Send a message to an Attendee Don't Miss These Special Events Annual Session Receptions San Diego Hotels Shuttle Bus Service Hotel and Travel Instructions Convocation ... Especially for ACP-ASIM Associates, Residents, Fellows-in-Training, and Medical Students

79. Hyperlipidemia And Angina hyperlipidemia and Angina. Implementing Coronary Risk Factor ModificationWhy, How, and In Whom Presented by Jonathan Abrams, MD http://www.acc.org/education/online/risks/hyperlipidemia/

var showMenu="ExpandMain:education;HighlightSub:online;"; // document.modified = "Tuesday March 12, 2002"; document.modified = "03/12/2002"; Hyperlipidemia and Angina Implementing Coronary Risk Factor Modification: Why, How, and In Whom Presented by Jonathan Abrams, M.D., F.A.C.C., Professor of Medicine (Cardiology), University Hospital, Division of Cardiology, University of New Mexico School of Medicine, Albuquerque, New Mexico Introduction This is an edited transcript of a talk presented by Jonathan Abrams, M.D., F.A.C.C. at the Heart House Learning Center. Because of the increased cardiovascular risk associated with elevated levels of total and LDL cholesterol, many investigators have studied the effects of lipid reduction in patients with coronary artery disease. The results have been encouraging. At this time, I would like to present recent findings about the benefits of one specific class of lipid-lowering drugs - the statins - in the treatment of angina pectoris. I will begin my discussion with a presentation of a case history of a patient with angina.

80. Hyperlipidemia hyperlipidemia. by Chick Newman. Primary idiopathic hyperlipidemia has been reportedto be familial in Miniature Schnauzers and Beagles, and some mixed breeds. http://www.newmanveterinary.com/Hyperlipidemia.html

H y p e r l i p i d e m i a by Chick Newman Introduction Etiology Lipid Classification Graphics ... Treatment Introduction: Primary idiopathic hyperlipidemia has been reported to be familial in Miniature Schnauzers and Beagles, and some mixed breeds. It has been seen sporadically in other breeds, e.g. Poodles and Shelties, as well, Infrequently it has been reported in cats. Secondary hyperlipidemia occurs as a result of another disease process. For example, it has been seen in association with diabetes pancreatitis hyperadrenocorticism and hypothyroidism Etiology: This is a metabolically complex disease of lipid -lipoprotein metabolism and the exact etiology is not fully appreciated. The familial type in schnauzers may involve defects lipoprotein lipase and/or Apoprotein C-II , a required cofactor for lipoprotein lipase activity (see figure below for roles of enzyme and cofactors in lipid metabolism). This defect causes a failure to breakdown chylomicrons (most common) and/or VLDL , and results in excessive levels of circulating triglycerides. It is the elevated concentration of triglycerides that is responsible for the clinical signs Classification: Lipids are derived from exogenous chylomicrons ) and endogenous sources. Lipids have been classified as:

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 4     61-80 of 97    Back | 1  | 2  | 3  | 4  | 5  | Next 20